A randomized trial involving all hospitals in London, UK, has found no difference in survival at 30 days in patients with resuscitated cardiac arrest in the community who were taken by ambulance to a cardiac arrest center compared with those delivered to the geographically closest emergency department.
Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins
Medtronic announced FDA approval of its first disposable, all-in-one continuous glucose monitor (CGM) Simplera, which is half the size of the maker’s previous devices. Over
August 14, 2024